Used in research as a potential metal chelator due to the presence of hydroxyquinoline moiety, which is known for its ability to bind metal ions. This property makes it a candidate for studies in neurodegenerative diseases where metal ion dysregulation is involved, such as Alzheimer's and Parkinson’s. The compound may also serve as a scaffold in the development of enzyme inhibitors, particularly targeting proteases or kinases, owing to its amide linkage and aromatic framework. Additionally, its structural features support exploration in fluorescence-based assays, where it can act as a probe for detecting metal ions or monitoring cellular processes. Limited solubility may restrict use in aqueous biological systems without modification.